A Fifteen‐Gene Classifier to Predict Neoadjuvant Chemotherapy Responses in Patients with Stage IB to IIB Squamous Cervical Cancer

Neoadjuvant chemotherapy (NACT) remains an attractive alternative for controlling locally advanced cervical cancer. However, approximately 15–34% of women do not respond to induction therapy. To develop a risk stratification tool, 56 patients with stage IB‐IIB cervical cancer are included in 2 resea...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Xun, Wang, Xin, Cui, Zifeng, Liu, Jia, Huang, Xiaoyuan, Shi, Caixia, Zhang, Min, Liu, Ting, Du, Xiaofang, Li, Rui, Huang, Lei, Gong, Danni, Tian, Rui, Cao, Chen, Jin, Ping, Zeng, Zhen, Pan, Guangxin, Xia, Meng, Zhang, Hongfeng, Luo, Bo, Xie, Yonghui, Li, Xiaoming, Li, Tianye, Wu, Jun, Zhang, Qinghua, Chen, Gang, Hu, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Full Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132153/
https://www.ncbi.nlm.nih.gov/pubmed/34026427
http://dx.doi.org/10.1002/advs.202001978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132153/
https://www.ncbi.nlm.nih.gov/pubmed/34026427
http://dx.doi.org/10.1002/advs.202001978

Ejemplares similares